Associate Professor
University of Florida
Rhonda M. Cooper-DeHoff, Pharm.D., M.S., is a graduate of the University of California, San Francisco School of Pharmacy and after completing a clinical residency moved to Gainesville in 1987 to work at Shands Hospital. In 1999 she transitioned to a faculty position, first in the COM (Division of Cardiology), and then in 2009 to the College of Pharmacy. She received her Masters Degree in the area of Clinical and Translational Research from the University of Florida. Dr. Cooper-DeHoff’s area of research interest include hypertension and cardiovascular disease pharmacogenetics, as well as the factors that influence outcomes with antihypertensive and cardiovascular treatments. She also has interest in the area of antihypertensive drug use and adverse metabolic effects including diabetes, as well as the area of dietary supplements. In total, she has over 250 publications and many have been of high impact, helping to define demographic, clinical, metabolic, metabolomic and genetic and pharmacogenetic factors associated with responses to antihypertensive drugs and cardiovascular outcomes with antihypertensive therapy. She is currently conducting research in the area of ‘big data’ science including the use of EHR data from multiple health systems to conduct real world longitudinal surveillance of important blood pressure control and process metrics, as well as preemptive genetics and pharmacogenetics testing in multiple therapeutic areas. She is a Fellow of the American College of Cardiology, the American Heart Association and the American College of Clinical Pharmacy.
IGNITE Pragmatic Clinical Trials Network Trial Results
Friday, May 30, 2025
3:00 PM - 4:00 PM East Coast USA Time